DE3785198T3 - Liposomes präparat und antibiotikum. - Google Patents

Liposomes präparat und antibiotikum.

Info

Publication number
DE3785198T3
DE3785198T3 DE3785198T DE3785198T DE3785198T3 DE 3785198 T3 DE3785198 T3 DE 3785198T3 DE 3785198 T DE3785198 T DE 3785198T DE 3785198 T DE3785198 T DE 3785198T DE 3785198 T3 DE3785198 T3 DE 3785198T3
Authority
DE
Germany
Prior art keywords
antibiotic
liposomes preparation
preparation
liposomes
aminoglycoside
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3785198T
Other languages
English (en)
Other versions
DE3785198D1 (de
DE3785198T2 (de
Inventor
B Bally
E Bolcsak
R Cullis
S Janoff
D Mayer
P Lenk
Ann Jedrusiak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elan Pharmaceuticals LLC
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27130236&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3785198(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of DE3785198D1 publication Critical patent/DE3785198D1/de
Publication of DE3785198T2 publication Critical patent/DE3785198T2/de
Application granted granted Critical
Publication of DE3785198T3 publication Critical patent/DE3785198T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
DE3785198T 1986-12-23 1987-01-13 Liposomes präparat und antibiotikum. Expired - Lifetime DE3785198T3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94639886A 1986-12-23 1986-12-23
US94639186A 1986-12-23 1986-12-23
PCT/US1987/000077 WO1988004573A1 (en) 1986-12-23 1987-01-13 Liposome preparation and antibiotic

Publications (3)

Publication Number Publication Date
DE3785198D1 DE3785198D1 (de) 1993-05-06
DE3785198T2 DE3785198T2 (de) 1993-07-15
DE3785198T3 true DE3785198T3 (de) 1999-09-02

Family

ID=27130236

Family Applications (3)

Application Number Title Priority Date Filing Date
DE3751871A Expired - Fee Related DE3751871D1 (de) 1986-12-23 1987-01-13 Guanidinaminoglycosid enthaltende Liposome
DE3751871T Expired - Lifetime DE3751871T4 (de) 1986-12-23 1987-01-13 Guanidinaminoglycosid enthaltende Liposome
DE3785198T Expired - Lifetime DE3785198T3 (de) 1986-12-23 1987-01-13 Liposomes präparat und antibiotikum.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE3751871A Expired - Fee Related DE3751871D1 (de) 1986-12-23 1987-01-13 Guanidinaminoglycosid enthaltende Liposome
DE3751871T Expired - Lifetime DE3751871T4 (de) 1986-12-23 1987-01-13 Guanidinaminoglycosid enthaltende Liposome

Country Status (8)

Country Link
EP (3) EP0500143A3 (de)
JP (1) JP2528153B2 (de)
AT (2) ATE87503T1 (de)
AU (1) AU609711B2 (de)
CA (1) CA1314481C (de)
DE (3) DE3751871D1 (de)
IL (2) IL97538A (de)
WO (1) WO1988004573A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920016A (en) * 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
US5269979A (en) * 1988-06-08 1993-12-14 Fountain Pharmaceuticals, Inc. Method for making solvent dilution microcarriers
CA1340241C (en) * 1988-06-08 1998-12-15 Fountain Pharmaceuticals, Inc. Method for marking solvent dilution microcarriers
BE1001869A3 (fr) * 1988-10-12 1990-04-03 Franz Legros Procede d'encapsulation liposomiale d'antibiotiques aminoglucosidiques, en particulier de la gentamycine.
US5843473A (en) * 1989-10-20 1998-12-01 Sequus Pharmaceuticals, Inc. Method of treatment of infected tissues
CA2046997C (en) * 1990-07-16 2000-12-12 Hiroshi Kikuchi Liposomal products
US6060080A (en) * 1990-07-16 2000-05-09 Daiichi Pharmaceutical Co., Ltd. Liposomal products
PT100486B (pt) * 1992-05-14 1999-07-30 Ineti Inst Nac Engenh E Tecnol Aminoglucosidos lipossomais com altas eficacia de encapsulacao e actividade terapeutica, nomeadamente a netilmicina, e processo para a sua preparcao
WO1994012155A1 (en) * 1992-12-02 1994-06-09 Vestar, Inc. Antibiotic formulation and process
US5958449A (en) 1992-12-02 1999-09-28 Nexstar Pharmaceuticals, Inc. Antibiotic formulation and use for bacterial infections
CN1040177C (zh) * 1993-04-23 1998-10-14 江苏省微生物研究所 一种含1-N-乙基庆大霉素C1a或其盐的药用制剂及制备方法
US5759571A (en) * 1993-05-11 1998-06-02 Nexstar Pharmaceuticals, Inc. Antibiotic formulation and use for drug resistant infections
ES2149955T3 (es) * 1993-11-16 2000-11-16 Skyepharma Inc Vesiculas con liberacion controlada de sustancias activas.
US6613352B2 (en) 1999-04-13 2003-09-02 Universite De Montreal Low-rigidity liposomal formulation
EP1404297B1 (de) 2001-06-12 2011-04-27 The Johns Hopkins University School Of Medicine Reservoirvorrichtung für die intraokulare arzneimittelabgabe
US20050085432A1 (en) * 2001-12-26 2005-04-21 Aviva Lapidot Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
JP5118302B2 (ja) * 2002-10-29 2013-01-16 トランセイブ， インク． 抗感染剤の徐放
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
CA2838111C (en) 2005-12-08 2016-01-19 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
US20100196455A1 (en) 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
SG173167A1 (en) 2009-01-29 2011-08-29 Forsight Labs Llc Posterior segment drug delivery
US8623395B2 (en) 2010-01-29 2014-01-07 Forsight Vision4, Inc. Implantable therapeutic device
WO2013022801A1 (en) 2011-08-05 2013-02-14 Forsight Vision4, Inc. Small molecule delivery with implantable therapeutic device
EP2600930B1 (de) 2010-08-05 2021-02-17 ForSight Vision4, Inc. Injektionsapparat zur verabreichung von medikamenten
CA2807554C (en) 2010-08-05 2021-10-26 Forsight Vision4 Inc. Implantable therapeutic device
EP2600876B1 (de) 2010-08-05 2015-04-29 Forsight Vision4, Inc. Verfahren und vorrichtung zur verabreichung kombinierter arzneimittel
CA2818612C (en) 2010-11-19 2020-12-29 Forsight Vision4, Inc. Therapeutic agent formulations for implanted devices
EP2726016B1 (de) 2011-06-28 2023-07-19 ForSight Vision4, Inc. Vorrichtung zum sammeln einer flüssigkeitsprobe aus einer reservoirkammer einer therapeutischen vorrichtung für das auge
PT2755600T (pt) 2011-09-16 2021-04-19 Forsight Vision4 Inc Aparelhos de troca de fluidos
US10010448B2 (en) 2012-02-03 2018-07-03 Forsight Vision4, Inc. Insertion and removal methods and apparatus for therapeutic devices
CN108743537B (zh) 2012-05-21 2021-06-11 英斯麦德公司 治疗肺部感染的***
US10124066B2 (en) 2012-11-29 2018-11-13 Insmed Incorporated Stabilized vancomycin formulations
WO2014152959A1 (en) 2013-03-14 2014-09-25 Forsight Vision4, Inc. Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
US9526654B2 (en) 2013-03-28 2016-12-27 Forsight Vision4, Inc. Ophthalmic implant for delivering therapeutic substances
ES2820226T3 (es) 2014-05-15 2021-04-20 Insmed Inc Métodos para tratar infecciones pulmonares micobacterianas no tuberculosas
CN106687079B (zh) 2014-07-15 2019-10-11 弗赛特影像4股份有限公司 眼睛植入输送装置和方法
EP3177289A4 (de) 2014-08-08 2018-03-21 Forsight Vision4, Inc. Stabile und lösliche formulierungen von rezeptortyrosinkinaseinhibitoren und verfahren zur herstellung davon
WO2016077371A1 (en) 2014-11-10 2016-05-19 Forsight Vision4, Inc. Expandable drug delivery devices and method of use
US11432959B2 (en) 2015-11-20 2022-09-06 Forsight Vision4, Inc. Porous structures for extended release drug delivery devices
EP3439591B1 (de) 2016-04-05 2020-09-23 ForSight Vision4, Inc. Implantierbare okulare arzneimittelabgabevorrichtungen
WO2019103906A1 (en) 2017-11-21 2019-05-31 Forsight Vision4, Inc. Fluid exchange apparatus for expandable port delivery system and methods of use
EP3773505A4 (de) 2018-03-30 2021-12-22 Insmed Incorporated Verfahren zur kontinuierlichen herstellung von liposomalen arzneimittelprodukten

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993754A (en) * 1974-10-09 1976-11-23 The United States Of America As Represented By The United States Energy Research And Development Administration Liposome-encapsulated actinomycin for cancer chemotherapy
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
US4086257A (en) * 1976-10-12 1978-04-25 Sears Barry D Phosphatidyl quaternary ammonium compounds
CH624011A5 (de) * 1977-08-05 1981-07-15 Battelle Memorial Institute
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4397846A (en) * 1981-05-15 1983-08-09 Murray Weiner Storage-stable lipid vesicles and method of preparation
JPS59500952A (ja) * 1982-03-29 1984-05-31 ザ　リポソ−ム　カンパニ−、インコ−ポレ−テッド 安定なプルリラメラベシクル類
US4522803A (en) * 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
SU1123697A1 (ru) * 1982-08-18 1984-11-15 Всесоюзный научно-исследовательский институт фармации Способ получени липосомальной формы антибиотиков стрептомицинового р да
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
JPS59210013A (ja) * 1983-05-04 1984-11-28 Ajinomoto Co Inc 活性物質含有リポソ−ム
US4515736A (en) * 1983-05-12 1985-05-07 The Regents Of The University Of California Method for encapsulating materials into liposomes
WO1985001103A1 (en) * 1983-08-31 1985-03-14 Diagraph Corporation Ink jet printing apparatus
US4532089A (en) * 1984-01-14 1985-07-30 Northwestern University Method of preparing giant size liposomes
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
JPH0655676B2 (ja) * 1984-07-26 1994-07-27 ザ リポソ−ム カンパニ−、インコ−ポレ−テツド 脂質小胞体中に含有された抗菌物質の混合物による抗菌活性の増高
JPH0680767A (ja) * 1992-09-03 1994-03-22 Matsushita Electric Ind Co Ltd 電子・電気機器用エポキシ樹脂組成物

Also Published As

Publication number Publication date
AU6934587A (en) 1988-07-15
EP0498471B1 (de) 1996-08-14
DE3751871T4 (de) 1998-03-26
EP0295248B1 (de) 1993-03-31
JPH01501619A (ja) 1989-06-08
EP0295248A4 (de) 1988-12-19
EP0498471A2 (de) 1992-08-12
ATE87503T1 (de) 1993-04-15
WO1988004573A1 (en) 1988-06-30
IL97538A0 (en) 1992-06-21
AU609711B2 (en) 1991-05-09
EP0500143A2 (de) 1992-08-26
DE3751871D1 (de) 1996-09-19
DE3785198D1 (de) 1993-05-06
CA1314481C (en) 1993-03-16
EP0498471A3 (en) 1993-03-03
DE3785198T2 (de) 1993-07-15
JP2528153B2 (ja) 1996-08-28
ATE141166T1 (de) 1996-08-15
EP0295248B2 (de) 1999-04-28
IL97538A (en) 1995-03-15
EP0500143A3 (en) 1993-03-03
EP0295248A1 (de) 1988-12-21
DE3751871T2 (de) 1997-03-13

Similar Documents

Publication Publication Date Title
DE3785198D1 (de) Liposomes praeparat und antibiotikum.
ATE38672T1 (de) 7-oxabicycloheptan aminosubstituierte prostaglandinaehnliche verbindungen.
ZA857270B (en) Tetralin derivatives,their preparation and their use
FI941245A (fi) Menetelmä 2'-deoksiguanosiinin asyylijohdannaisten valmistamiseksi
HUT45538A (en) Process for producing quinoline derivatives and pharmaceutical compositions containing them
ES8201582A1 (es) Un procedimiento para la preparacion de derivados de triazo-lopiridazina
ES2079391T3 (es) Procedimiento para la obtencion de 2,7-diazabiciclo(3.3.0)octanos.
ES2093666T3 (es) Derivados de los acidos 7-(2,7-diazabiciclo(3,3.0)octil)-3-quinolon- y -naftiridon carboxilicos.
EP0331092A3 (en) Alpha-amino-carboxylic-acid derivatives, their preparation and use
PT88493A (pt) Process for preparing milbemycin derivatives useful as antiparasitic agents
FI864970A (fi) Nya kristallina salter av aryloxi-propanolaminer, foerfarande foer deras framstaellning och deras anvaendning.
PT92270A (pt) Processo para a preparacao de solvatos de um antibiotico beta-lactamico
AU553874B2 (en) Thiazaspirane derivatives
ES2129053T3 (es) Nuevos derivados de fosfolipidos.
HUT54682A (en) Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds
FI93121B (fi) Menetelmä lääkeaineena käyttökelpoisten 5H-pyrido/1',2':4,5/tiadiatsino/2,3-a/bentsimidatsoliumjohdannaisten valmistamiseksi
ATE133177T1 (de) 3'-deamino-4'-deoxy-4'-amino-8-fluoranthracycli e und verfahren zu ihrer herstellung
ES2045146T3 (es) Avermectinas etiladas.
FI911616A (fi) Substituerade 3-tia- eller 3-oxa-alkyl -flavoner, foerfarande foer deras framstaellning, deras anvaendning, pao dessa foereningar baserade laekemedel samt mellanprodukter.
RO94422A (ro) Procedeu de preparare a derivatilor antibioticului a-21978c
FR2597104B1 (fr) Procede de preparation de derives de la moranoline
PT69181A (fr) Procede de preparation de derives d'antibiotiques
ZA881322B (en) Benzylaminoaryl-dihydropyridinelactones,process for their preparation,and their use in medicaments
RO73070A2 (ro) Procedeu pentru prepararea unor concentrate de paminturi rare
BE874983A (fr) Procede de preparation d'antibiotiques de la classe des beta-lactames